n.duarte
TL2 Moderator · Osaka
Contributes reviews on supplier material. Based in Osaka.
Joined 18 September 2024 · last posted 3d
67 posts, newest first. Showing up to 150.
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #75 · Evidence › Journal club · 25 Jul 2026 · 27 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
Impurity thresholds: where the common numbers come from Replied, post #12 · Analytics › Impurities & related substances · 22 Jul 2026 · 0 likes Truncation products: fragments from incomplete synthesis or from degradation. They elute quite differently from the intact peptide because they are much smaller and…
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #60 · Practice › Administration · 21 Jul 2026 · 15 likes Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh needle for injection reduces tissue drag and can decrease…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #94 · Evidence › Journal club · 10 Jul 2026 · 3 likes On post #90 — agreed on the reasoning, with one qualification. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most…
-
Revisiting: What pooling buys you and what it destroys Replied, post #85 · Evidence › Meta-analyses · 9 Jul 2026 · 1 like Funnel plots: a plot of study effect size versus sample size that helps detect publication bias. If small studies are missing on the negative side, the funnel is…
-
Follow-up: Sleep quality changes during weight loss Replied, post #57 · Wellbeing › Sleep · 29 Jun 2026 · 0 likes Coming back to post #55, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #49 · Sourcing › Independent verification · 28 Jun 2026 · 7 likes This follows post #46 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Spreadsheets: an appreciation — what changed since Replied, post #78 · Lounge › Off topic · 22 Jun 2026 · 7 likes I read post #76 twice before replying, because I had assumed the opposite. Science communication: if you come across an interesting science paper or article about…
-
Second pass at: Programming during a large energy deficit Replied, post #31 · Nutrition & Training › Resistance training · 17 Jun 2026 · 17 likes Programming while losing weight quickly: realistic expectations are crucial. Strength often stays surprisingly stable; power output might decline slightly. Expecting…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #78 · Access › Insurance & coverage · 10 Jun 2026 · 32 likes Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite specific criteria. Understanding the criterion is the first step in satisfying…
-
Risk-of-bias tools and the judgement they conceal — does this still hold? Replied, post #13 · Evidence › Meta-analyses · 7 Jun 2026 · 1 like Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
Official shortage notices and what they authorise Replied, post #82 · Access › Shortages · 2 Jun 2026 · 0 likes Allocation and rationing: during severe shortages, suppliers might ration allocation to prescribers. Understanding rationing policies from your prescriber matters for…
-
Official shortage notices and what they authorise Replied, post #67 · Access › Shortages · 24 May 2026 · 11 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Prescription portability between countries Replied, post #32 · Access › International · 14 May 2026 · 0 likes Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates currency and intermediary issues but has other risks.
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #64 · Devices › Syringes & needles · 27 Apr 2026 · 1 like Coming back to post #62, because the follow-up matters more than the original answer. Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #38 · Evidence › Journal club · 23 Apr 2026 · 5 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
GLP-1 receptor distribution: central and peripheral Replied, post #36 · Pharmacology › Receptor biology · 22 Apr 2026 · 0 likes post #35 is right about the mechanism and I think understates the practical bit. Central versus peripheral action: GLP-1 agonism works through both central nervous…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #89 · Practice › Interactions · 18 Apr 2026 · 2 likes post #88 answers the question as asked. The question underneath it is different. Metformin: commonly co-administered and relevant to gastrointestinal tolerability.…
-
Preprint servers and what screening they do — the long version Replied, post #12 · Evidence › Preprints · 9 Apr 2026 · 18 likes Discussing preprints in this community: bring them in for early discussion, label them clearly as preprints, invite peer critique, and be prepared for the discussion to…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #61 · Analytics › Mass spectrometry · 8 Mar 2026 · 15 likes post #60 answers the question as asked. The question underneath it is different. Purity and identity are different questions: LC-MS establishes that the species at a…
-
A parcel stationary at a customs facility for nine days — does this still hold? Replied, post #8 · Sourcing › Logistics · 6 Mar 2026 · 1 like Documentation after arrival: photograph the parcel and its contents on arrival. If something later turns out wrong (damage, loss, wrong item) you have evidence of the…
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #41 · Compounds › Cagrilintide & amylin analogues · 4 Mar 2026 · 13 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #55 · Outcomes › Body composition · 17 Feb 2026 · 1 like This follows post #52 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
MS/MS sequence confirmation: what it costs and when it is worth it — what changed since Replied, post #3 · Analytics › Mass spectrometry · 16 Feb 2026 · 0 likes Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical mass divided by theoretical mass, multiplied by a million. A…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #23 · Practice › Storage & stability · 12 Feb 2026 · 0 likes Beyond-use dating: the date after which a prepared solution should not be used. It is an estimate based on how fast the solution degrades under stated storage, not on…
-
Revisiting: Absolute versus relative contraindications Replied, post #12 · Safety › Contraindications · 19 Jan 2026 · 0 likes Worth separating two things that post #8 runs together. History of pancreatitis: these compounds can rarely trigger pancreatitis. History of pancreatitis increases…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #88 · Compounds › Oral incretins · 18 Jan 2026 · 23 likes This follows post #85 rather than contradicting it. PIONEER programme is phase 3 for oral semaglutide. The trials cover multiple indications and durations. Reading them…
-
Filter needles: when they help and what they cost you Replied, post #26 · Devices › Syringes & needles · 14 Jan 2026 · 23 likes On post #22 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
A partial dose because the pen emptied mid-injection Replied, post #96 · Practice › Administration · 10 Jan 2026 · 0 likes Worth separating two things that post #92 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #3 · Practice › Side effects · 25 Dec 2025 · 0 likes Gallbladder complications: rapid weight loss increases the risk of gallstone formation. The mechanism is not specific to this drug class. The risk is greatest in the…
-
The decimal-point error, and the habit that catches it Replied, post #34 · Practice › Reconstitution · 15 Dec 2025 · 0 likes On post #30 — agreed on the reasoning, with one qualification. Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100…
-
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #28 · Devices › Pens & autoinjectors · 12 Dec 2025 · 0 likes I read post #26 twice before replying, because I had assumed the opposite. Injection duration: most pens deliver the dose over several seconds. Holding the button down…
-
Sleep quality changes during weight loss — what changed since Replied, post #67 · Wellbeing › Sleep · 17 Nov 2025 · 8 likes Stimulants and sleep: if supplementing with caffeine or other stimulants for energy during weight loss, timing and dose matter for sleep. Evening stimulant use…
-
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #57 · Compounds › Tirzepatide · 27 Oct 2025 · 10 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Progressive overload when the scale is falling Replied, post #8 · Nutrition & Training › Resistance training · 26 Oct 2025 · 3 likes Deload weeks: periodic weeks (every 4 to 8 weeks) with reduced volume and intensity can help with recovery and sometimes reveal strength gains that got obscured by…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #38 · Practice › Interactions · 25 Oct 2025 · 2 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #79 · Compounds › Semaglutide · 21 Oct 2025 · 0 likes The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4 half-lives you are not approaching steady state yet, which is…
-
New subcategory: rationale and scope Replied, post #24 · Meta › Announcements · 14 Oct 2025 · 12 likes Implementation timeline: announcements include when a change takes effect. Marking the date helps you know whether the change is already in effect.
-
Temperature loggers worth the money — the long version Replied, post #55 · Devices › Cold chain · 12 Oct 2025 · 0 likes Worth separating two things that post #51 runs together. Domestic refrigeration: most lyophilised peptides are stored at 2–8 °C (35–46 °F). That is standard…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #23 · Sourcing › Vendor reports · 10 Oct 2025 · 21 likes Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from a different lot is not evidence about your vial.
-
Where to report an adverse event officially, by region — a second dataset Replied, post #3 · Safety › Adverse events · 7 Oct 2025 · 0 likes Reporting to regulatory agencies: if you have had a serious event, reporting it to the regulatory agency in your country can help with signal detection across the…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #64 · Evidence › Preprints · 30 Sep 2025 · 16 likes post #63 is right about the mechanism and I think understates the practical bit. Peer review as a filter: published papers have survived a review process that rejects…
-
Hypertension improvement and when medication needs revisiting Replied, post #32 · Clinical › Comorbidities · 30 Aug 2025 · 0 likes Type 2 diabetes: the population with the largest evidence base for these compounds. The SURPASS and SUSTAIN programmes established glycaemic benefit. The renal and…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #12 · Compounds › Tirzepatide · 7 Jul 2025 · 0 likes post #11 is right about the mechanism and I think understates the practical bit. Storage and stability: published data on licensed tirzepatide formulations exists and…
-
Reading a regulatory notice rather than an article about it — what changed since Replied, post #28 · Sourcing › Regulatory · 26 Jun 2025 · 13 likes post #27 answers the question as asked. The question underneath it is different. Labelling and intended use: a compound sold as "research-use-only" does not change its…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #115 · Clinical › Comorbidities · 15 Jun 2025 · 32 likes post #114 is right about the mechanism and I think understates the practical bit. Hepatic steatosis and MASH: a phase 2 trial in semaglutide for steatohepatitis showed…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #26 · Sourcing › Regulatory · 15 Jun 2025 · 1 like Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption. The…
-
Sequence verification for an obscure compound: how it is done Replied, post #63 · Compounds › Other compounds · 15 Jun 2025 · 0 likes This subcategory exists because some people will research compounds outside the main groups discussed here. The standard of evidence and honesty about its limits…
-
Counter-ion content and its effect on measured mass Replied, post #59 · Analytics › Mass spectrometry · 8 Jun 2025 · 13 likes Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal. Report whether desalting was used, because it can affect the…
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #36 · Regional › UK & Ireland · 10 May 2025 · 14 likes Coming back to post #34, because the follow-up matters more than the original answer. Cross-border arrangements: some people source from other EU countries. Rules on…
-
Reading a trial's population section before its results — does this still hold? Replied, post #77 · Evidence › Trials · 7 May 2025 · 0 likes post #76 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Telehealth prescribing models in the US Replied, post #83 · Regional › North America · 11 Apr 2025 · 0 likes Cross-border purchase: buying in the US and bringing to Canada or vice versa involves both countries' import rules. The medication is legal but crossing borders with it…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #67 · Compounds › Semaglutide · 7 Apr 2025 · 0 likes This follows post #64 rather than contradicting it. The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not…
-
Criticising the method without criticising the authors Replied, post #48 · Evidence › Study critique · 18 Mar 2025 · 5 likes post #47 answers the question as asked. The question underneath it is different. Publication bias: a single published positive trial is weaker evidence than multiple…
-
Scheduled maintenance and what will be unavailable Replied, post #69 · Meta › Announcements · 11 Mar 2025 · 17 likes Worth separating two things that post #65 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Adjudicated events and why the definition matters — the long version Replied, post #27 · Evidence › Trials · 28 Feb 2025 · 6 likes I read post #25 twice before replying, because I had assumed the opposite. Dropout is information: high dropout rates can indicate tolerability problems or lower…
-
A supplier that answers analytical questions with restated claims Replied, post #24 · Sourcing › Red flags · 14 Feb 2025 · 16 likes Unresponsiveness: a supplier that does not reply to reasonable requests for documentation or clarification is showing you something about how they operate.
-
Distinguishing a deletion sequence by mass alone Replied, post #31 · Analytics › Mass spectrometry · 30 Jan 2025 · 7 likes Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical mass divided by theoretical mass, multiplied by a million. A…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #119 · Compounds › Other compounds · 16 Nov 2024 · 0 likes Picking up post #116: that is the part I would want checked first. Reading a supplier's product description as a marketing document: that is exactly what it is. The…
-
Progressive overload when the scale is falling — one year on Replied, post #136 · Nutrition & Training › Resistance training · 8 Oct 2024 · 14 likes post #135 answers the question as asked. The question underneath it is different. Deload weeks: periodic weeks (every 4 to 8 weeks) with reduced volume and intensity…
-
Progressive overload when the scale is falling — one year on Replied, post #97 · Nutrition & Training › Resistance training · 27 Sep 2024 · 0 likes Picking up post #94: that is the part I would want checked first. Adaptation and plateau: if strength does not change for weeks, that is stability, not backsliding.…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #75 · Nutrition & Training › Hydration & electrolytes · 4 Sep 2024 · 0 likes Constipation and hydration: dehydration makes constipation worse. Increasing fluid intake is the first intervention for constipation alongside other measures.
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #2 · Analytics › Mass spectrometry · 8 Aug 2024 · 32 likes the opening post answers the question as asked. The question underneath it is different. Mass accuracy is expressed in parts per million. It is the difference between…
-
Taste changes and food aversion, reported and discussed Replied, post #5 · Practice › Side effects · 26 Jul 2024 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Circumference measurements as a poor man's composition estimate Replied, post #3 · Outcomes › Body composition · 16 Jul 2024 · 30 likes Picking up post #2: that is the part I would want checked first. Comparison to published data: the trials reported mean fat and lean mass changes. Individual results…
-
Follow-up: What this community means by "a source", in practical terms Started this topic · Start Here › Welcome · 10 Jul 2024 · 10 likes The question in the title: What this community means by "a source", in practical terms I will give what I have already checked below so nobody repeats it. I want to…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #40 · Practice › Dosing & titration · 6 Jul 2024 · 3 likes Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but is described by some people. The downside is that…